No Cover Image

Journal article 985 views

Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus

G. B. Bolli, D. R. Owens, David Owens Orcid Logo

Diabetes, Obesity and Metabolism, Volume: 16, Issue: 7, Pages: 588 - 601

Swansea University Author: David Owens Orcid Logo

Full text not available from this repository: check for access using links below.

DOI (Published version): 10.1111/dom.12253

Published in: Diabetes, Obesity and Metabolism
Published: 2014
URI: https://cronfa.swan.ac.uk/Record/cronfa26727
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2016-03-10T02:00:07Z
last_indexed 2018-02-09T05:09:01Z
id cronfa26727
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2017-03-07T16:07:51.6513816</datestamp><bib-version>v2</bib-version><id>26727</id><entry>2016-03-09</entry><title>Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus</title><swanseaauthors><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-03-09</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>16</volume><journalNumber>7</journalNumber><paginationStart>588</paginationStart><paginationEnd>601</paginationEnd><publisher/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-12-31</publishedDate><doi>10.1111/dom.12253</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2017-03-07T16:07:51.6513816</lastEdited><Created>2016-03-09T14:12:01.7325402</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>G. B.</firstname><surname>Bolli</surname><order>1</order></author><author><firstname>D. R.</firstname><surname>Owens</surname><order>2</order></author><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>3</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2017-03-07T16:07:51.6513816 v2 26727 2016-03-09 Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2016-03-09 BMS Journal Article Diabetes, Obesity and Metabolism 16 7 588 601 31 12 2014 2014-12-31 10.1111/dom.12253 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2017-03-07T16:07:51.6513816 2016-03-09T14:12:01.7325402 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine G. B. Bolli 1 D. R. Owens 2 David Owens 0000-0003-1002-1238 3
title Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
spellingShingle Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
David Owens
title_short Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
title_full Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
title_fullStr Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
title_full_unstemmed Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
title_sort Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
author_id_str_mv 2fd4b7c3f82c6d3bd546eff61ff944e9
author_id_fullname_str_mv 2fd4b7c3f82c6d3bd546eff61ff944e9_***_David Owens
author David Owens
author2 G. B. Bolli
D. R. Owens
David Owens
format Journal article
container_title Diabetes, Obesity and Metabolism
container_volume 16
container_issue 7
container_start_page 588
publishDate 2014
institution Swansea University
doi_str_mv 10.1111/dom.12253
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 0
active_str 0
published_date 2014-12-31T03:32:09Z
_version_ 1763751315161219072
score 11.037603

Similar Items